
GC19120
DBPR108
Also known as (2S,4S)-4-fluoro-1-[2-[(2-methyl-4-oxo-4-pyrrolidin-1-ylbutan-2-yl)amino]acetyl]pyrrolidine-2-carbonitrile
DBPR108 is a potent, selective, and orally bioavailable dipeptide-derived inhibitor of DPP4 with IC50 of 15 nM; no inhibition on DDP8 and DPP9
ChemicalCAS1186426-66-3MW324.39FormulaC16H25FN4O2
- CAS number
- 1186426-66-3
- Molecular weight
- 324.39
- Formula
- C16H25FN4O2
- Solubility
- DMSO : ≥ 25 mg/mL (77·07 mM)
- InChIKey
- VQKSCYBKUIDZEI-STQMWFEESA-N
- Catalogue number
- GC19120
- Brand
- GLPBIO
Computed properties PubChem CID 44201003 · XLogP 0.2 · TPSA 76.4 Ų · H-bond donors 1
- XLogP
- 0.2
- TPSA
- 76.4 Ų
- H-bond donors
- 1
- H-bond acceptors
- 5
- Rotatable bonds
- 5
- Heavy atoms
- 23
SMILES CC(C)(CC(=O)N1CCCC1)NCC(=O)N2C[C@H](C[C@H]2C#N)F
Computed descriptors from PubChem (CID 44201003), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il